RedCo II Master Fund, L.P. has an estimated net worth of $255 Million. This is based on reported shares across multiple companies, which include MedAvail Holdings, Inc., Augmedix, Inc., ADC Therapeutics SA, and FATE THERAPEUTICS INC.

2024 was RedCo II Master Fund, L.P.'s most active year for acquiring shares with 32 total transactions. RedCo II Master Fund, L.P.'s most active month to acquire stocks was the month of December. 2024 was RedCo II Master Fund, L.P.'s most active year for disposing of shares, totalling 12 transactions. RedCo II Master Fund, L.P.'s most active month to dispose stocks was the month of March. 2025 saw RedCo II Master Fund, L.P. paying a total of $126,780,680.83 for 35,891,807 shares, this is the most they've acquired in one year. In 2024 RedCo II Master Fund, L.P. cashed out on 40,706,526 shares for a total of $75,782,226.91, their largest year based on trade value.